Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 46 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 63%

Novo Nordisk Notícia

Eli Lilly,Pharmaceutical Industry,Top Picks

Novo Nordisk (NVO) and Eli Lilly (LLY) both made headlines recently with positive drug trial results for their respective GLP-1 weight-loss drugs, as well as...

. While these names have been often cited as top picks in the pharmaceutical industry, are there hidden gems to look out for or do Eli Lilly and Novo Nordisk remain at the top of the class?"I think for me, Novo and Lilly are still going to be the top two.

I mean, investors are always looking at the health care space for the the next major breakthrough or scientific advancement. And we're gonna have data on that um roughly a year from now, maybe a little bit later than a year from now. Well, yeah, I mean, I think for me, Novo and Lily are still gonna be the top two, you know, as long as they're dominating in, in this kind of section of the market, um it's really tough to, you know, not ride these a little bit longer.

Not precisely sure when, but they're looking at, you know, the use of the weight loss drug on a monthly basis that's versus Lilian Novo um weekly.I mean, I've been pretty bullish on Merck all year given valuation, given the fact that they seem to be doing a lot of smart things from a business development standpoint to kind of dilute the effect of Kruta losing patent exclusivity closer to 2030.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 47. in BR

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 marketGLP-1 weight-loss drugs have been major revenue generators for pharmaceutical companies such as Eli Lilly (LLY) and Novo Nordisk (NVO). Goldman Sachs US Lead...
Fonte: YahooFinanceCA - 🏆 47. / 63 Consulte Mais informação »